After XSJ intervention, the expression levels of these molecules increased, suggesting that XSJ might block the progression of liver fibrosis by inhibiting the TGF-β1/Smads signaling pathway (Fig. 8C). This evidence concerns the gene TGFB1 and Hepatic fibrosis.